MedTrace Logo

Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release

NCT00367302 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2013-05-01

No results posted yet for this study

Summary

The purpose of the study is to determine the feasibility of providing buprenorphine maintenance to opioid-dependent offenders in a jail setting and of transitioning those patients to buprenorphine maintenance in the community after their release.

Conditions

  • Opiate Addiction

Interventions

DRUG

buprenorphine

maintenance

DRUG

methadone

maintenance

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Western Michigan University

    collaborator OTHER

  • New York City Department of Health and Mental Hygiene

    collaborator OTHER_GOV

  • National Development and Research Institutes, Inc.

    lead OTHER

Principal Investigators

  • Stephen Magura, Ph.D. · Western Michigan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2008-01-31
Completion
2008-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00367302 on ClinicalTrials.gov